Search - tctmd.com

Displaying 281 - 300 of 302

Sort: Relevancy | Date

Presentation TCT 2012

Relationship Between Elevated BNP Levels in STEMI and Clinical Outcomes: The HORIZONS-AMI Trial

Presenter: Rudolf Jarai, Kurt Huber, Ke S. Xu, Bimmer Claessen, Georg Dangas, Roxana Mehran, Gregg Stone

January 03, 2012

Presentation TCT 2012

Relationship Between Angiographic Dynamic and Densitometric Assessment of Myocardial Reperfusion and Survival in Patients with Acute Myocardial Infarction Treated with Primary...

Presenter: Sorin J. Brener, Ecaterina Cristea, Roxana Mehran, Ovidiu Dressler, Alexandra J. Lansky, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

Predictors of Major Adverse Events in Female Patients with Acute Myocardial Infarction undergoing Primary PCI: Three Year Results from the HORIZONS-AMI Study

Presenter: Jennifer Yu, Roxana Mehran, Ke Xu, Avery E. Clark, Rebecca Pinnelas, Bernhard Witzenbichler, Ran Kornowski, Giulio Gaugliumi, Eugenia Nikolsky, Bruce R. Brodie, Alexandra J. Lansky, George Dangas, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

Outcomes of Women after Acute Myocardial Infarction: Results from the HORIZONS-AMI Study

Presenter: Jennifer Yu, Roxana Mehran, Liliana Grinfeld, Ke Xu, Martin Fahy, Eugenia Nikolsky, Rebecca Pinnelas, Avery E. Clark, Bruce R. Brodie, Martin Mockel, Bernard Witzenbichler, Ran Kornowski, Dariusz Dudek, Alexandra J. Lansky, George Dangas, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

Extent, Characterization, and Clinical Implications of Untreated Lesions with High Plaque Burden after Successful Percutaneous Coronary Intervention: A PROSPECT Substudy.

Presenter: John A. McPherson, Akiko Maehara, Giora Weisz, Gary S. Mintz, Ecaterina Cristea, Roxana Mehran, Michael Foster, Stefan Verheye, Leroy Rabbani, Ke Xu, Martin Fahy, Alexandra J. Lansky, Bernard de Bruyne, Patrick W. Serruys, Gregg W. Stone

January 03, 2012

$Efficacy and Safety of Bivalirudin Compared to Unfractionated Heparin in Relation to the Use of “Preclose” Technique Using the Perclose Vascular Closure Device Among Patients...$

Presentation TCT 2012

Efficacy and Safety of Bivalirudin Compared to Unfractionated Heparin in Relation to the Use of “Preclose” Technique Using the Perclose Vascular Closure Device Among Patients...

Presenter: Shyam Poludasu, Usman Baber, Chabbra Sandeep, Jennifer Yu, Rebecca Pinnelas, Avery E. Clark, Roxana Mehran, George Dangas, Annapoorna S. Kini, Samin K. Sharma

January 03, 2012

Presentation TCT 2012

Cerebrovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Undergoing a Primary PCI Management Strategy: Analysis from the HORIZONS-AMI Trial

Presenter: Eugenia Nikolsky, Bernard J. Gersh, Dangas D. George, Shing-Chiu Wong, Ke Xu, Martin Fahy, Roxana Mehran, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

Bivalirudin Use During Percutaneous Coronary Intervention Improves Clinical and Economic Outcomes in Diabetic Women

Presenter: Erin M. Galbraith, Roxana Mehran, Chandan Devireddy, Henry A. Liberman, Steven V. Manoukian, Michele D. Voeltz

January 03, 2012

Presentation TCT 2012

Are Adverse Events Following an Invasive Strategy in Patients with Non ST-Segment Elevation Acute Coronary Syndromes (NSTEACS) More Frequent at US Sites vs Non US Sites...

Presenter: Patrick Tobbia, Bruce R. Brodie, Thomas Stuckey, Brent T. McLaurin, David Cox, Martin Fahy, Ke Xu, Roxana Mehran, Gregg W. Stone

January 03, 2012

News Conference News

EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version

November 10, 2011

News Conference News

PARIS: Early DAPT Nonadherence, A Small Problem with Big Consequences

November 09, 2011

News Industry News

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

November 08, 2011

News Industry News

Data from REMEDEE Trial Featuring OrbusNeich's ComboTM Dual Therapy Stent to Be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011

November 01, 2011

News Industry News

News Daily News

BARC: New Bleeding Definitions Aim to Standardize Trial Endpoints

L.A. McKeown

June 17, 2011

News Industry News

PLC Ramps Up for U.S. Clinical Trial of RenalGuard®

June 02, 2011

News Conference News

Therapies Take on In-Stent Restenosis with Mixed Results

Caitlin E. Cox

April 15, 2011

News Conference News

Induced Diuresis with Automated Hydration Therapy Reduces CIN

April 05, 2011

Advertisement

Relationship Between Elevated BNP Levels in STEMI and Clinical Outcomes: The HORIZONS-AMI Trial

Relationship Between Angiographic Dynamic and Densitometric Assessment of Myocardial Reperfusion and Survival in Patients with Acute Myocardial Infarction Treated with Primary...

Predictors of Major Adverse Events in Female Patients with Acute Myocardial Infarction undergoing Primary PCI: Three Year Results from the HORIZONS-AMI Study

Outcomes of Women after Acute Myocardial Infarction: Results from the HORIZONS-AMI Study

Extent, Characterization, and Clinical Implications of Untreated Lesions with High Plaque Burden after Successful Percutaneous Coronary Intervention: A PROSPECT Substudy.

Efficacy and Safety of Bivalirudin Compared to Unfractionated Heparin in Relation to the Use of “Preclose” Technique Using the Perclose Vascular Closure Device Among Patients...

Cerebrovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Undergoing a Primary PCI Management Strategy: Analysis from the HORIZONS-AMI Trial

Bivalirudin Use During Percutaneous Coronary Intervention Improves Clinical and Economic Outcomes in Diabetic Women

Are Adverse Events Following an Invasive Strategy in Patients with Non ST-Segment Elevation Acute Coronary Syndromes (NSTEACS) More Frequent at US Sites vs Non US Sites...

EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version

PARIS: Early DAPT Nonadherence, A Small Problem with Big Consequences

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

Data from REMEDEE Trial Featuring OrbusNeich's ComboTM Dual Therapy Stent to Be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011

PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S.

In-hospital Bleeding after Primary PCI Increases Long-term Mortality

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

BARC: New Bleeding Definitions Aim to Standardize Trial Endpoints

PLC Ramps Up for U.S. Clinical Trial of RenalGuard®

Therapies Take on In-Stent Restenosis with Mixed Results

Induced Diuresis with Automated Hydration Therapy Reduces CIN

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content